Castella Maria, Jacquemont Celine, Thompson Elizabeth L, Yeo Jung Eun, Cheung Ronald S, Huang Jen-Wei, Sobeck Alexandra, Hendrickson Eric A, Taniguchi Toshiyasu
Howard Hughes Medical Institute, Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Biochemistry, Molecular Biology, and Biophysics Department, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
PLoS Genet. 2015 Oct 2;11(10):e1005563. doi: 10.1371/journal.pgen.1005563. eCollection 2015 Oct.
The Fanconi anemia (FA)-BRCA pathway mediates repair of DNA interstrand crosslinks. The FA core complex, a multi-subunit ubiquitin ligase, participates in the detection of DNA lesions and monoubiquitinates two downstream FA proteins, FANCD2 and FANCI (or the ID complex). However, the regulation of the FA core complex itself is poorly understood. Here we show that the FA core complex proteins are recruited to sites of DNA damage and form nuclear foci in S and G2 phases of the cell cycle. ATR kinase activity, an intact FA core complex and FANCM-FAAP24 were crucial for this recruitment. Surprisingly, FANCI, but not its partner FANCD2, was needed for efficient FA core complex foci formation. Monoubiquitination or ATR-dependent phosphorylation of FANCI were not required for the FA core complex recruitment, but FANCI deubiquitination by USP1 was. Additionally, BRCA1 was required for efficient FA core complex foci formation. These findings indicate that FANCI functions upstream of FA core complex recruitment independently of FANCD2, and alter the current view of the FA-BRCA pathway.
范可尼贫血(FA)-BRCA通路介导DNA链间交联的修复。FA核心复合物是一种多亚基泛素连接酶,参与DNA损伤的检测,并对两种下游FA蛋白FANCD2和FANCI(或ID复合物)进行单泛素化修饰。然而,对FA核心复合物自身的调控却知之甚少。在此,我们表明FA核心复合物蛋白被招募至DNA损伤位点,并在细胞周期的S期和G2期形成核灶。ATR激酶活性、完整的FA核心复合物以及FANCM-FAAP24对这种招募至关重要。令人惊讶的是,高效形成FA核心复合物灶需要FANCI而非其伙伴FANCD2。FA核心复合物的招募不需要FANCI的单泛素化或ATR依赖性磷酸化,但需要USP1对FANCI进行去泛素化。此外,高效形成FA核心复合物灶需要BRCA1。这些发现表明,FANCI在FA核心复合物招募的上游发挥作用,独立于FANCD2,并改变了目前对FA-BRCA通路的看法。